Results 151 to 160 of about 146,670 (267)

Pembrolizumab in recurrent or metastatic medullary thyroid cancer. [PDF]

open access: yesOncologist
Del Rivero J   +9 more
europepmc   +1 more source

Differences in the aggressiveness of familial versus sporadic non-medullary thyroid cancer: An unresolved controversy. [PDF]

open access: yesArch Endocrinol Metab
Miasaki FY   +5 more
europepmc   +1 more source

Long-term calcitonin after thyroidectomy for medullary thyroid cancer in MEN2A. [PDF]

open access: yesEndocr Relat Cancer
van den Berg ML   +8 more
europepmc   +1 more source

A phase 2 study of GI-6207 in patients with recurrent medullary thyroid cancer. [PDF]

open access: yesOncologist
Del Rivero J   +9 more
europepmc   +1 more source

Clinical presentation and outcomes of medullary thyroid cancer in two European countries: impact of diagnostic strategies. [PDF]

open access: yesEur Thyroid J
Ceruti D   +8 more
europepmc   +1 more source

Is hemithyroidectomy enough? Low risk of occult contralateral disease in sporadic medullary thyroid cancer. [PDF]

open access: yesEur Arch Otorhinolaryngol
Spörlein A   +6 more
europepmc   +1 more source

Prediction of distant metastases at diagnosis in medullary thyroid cancer: combining calcitonin with lymph node imaging. [PDF]

open access: yesJ Endocr Soc
Schonebaum LE   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy